Non-Invasive Cell Tracking with Brighter and Red-Transferred Luciferase for Potential Application in Stem Cell...

Area of Science:

• Regenerative Medicine
• Cell Biology
• Biotechnology

Background:

• Cell-based therapies hold promise for erectile dysfunction (ED).
• Effective tracking of transplanted cells is crucial for assessing therapeutic efficacy and safety.
• Novel labeling technologies are needed to monitor cell behavior in vivo.

Purpose of the Study:

• To evaluate the safety and efficacy of a novel mKATE-renLUC cell-labeling technology.
• To assess the impact of mKATE-renLUC labeling on human placental stromal cell (PSC) characteristics.
• To track the migration and distribution of labeled PSC in an ED rat model.

Main Methods:

• Human PSC were labeled with mKATE-renLUC via lentivirus.
• In vitro assays assessed cell viability, apoptosis, proliferation, migration, and differentiation.
• An ED rat model was used to track labeled PSC in vivo using IVIS imaging and histological analysis.

Main Results:

• mKATE-renLUC labeling did not significantly alter PSC viability, proliferation, migration, or differentiation potential compared to unlabeled cells.
• The paracrine profile of labeled PSC remained similar to unlabeled cells.
• In vivo tracking successfully monitored PSC migration and distribution in penile and other tissues.

Conclusions:

• The mKATE-renLUC labeling technology is safe and effective for tracking human PSC.
• This method offers a reliable approach for monitoring cell distribution and migration in regenerative medicine applications.
• The brighter fluorophore and codon-optimized luciferase enhance cell-tracking capabilities.